BMS 300 mg 3622 (Reyataz 300 mg)
Generic Name: atazanavir
Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Reyataz 300 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 300 mg 3622
Reyataz
- Generic Name
- atazanavir
- Imprint
- BMS 300 mg 3622
- Strength
- 300 mg
- Color
- Red / Blue
- Size
- 23.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
FD&C Blue No. 2,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
isopropyl alcohol,
ammonia,
propylene glycol,
butyl alcohol,
alcohol,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-3622 | |
| 54569-5864 | A-S Medication Solutions, LLC (repackager) |
| 54868-5838 | Physicians Total Care Inc. (repackager) |
| 35356-0114 | Lake Erie Medical and Surgical Supply (repackager) |
Related Images for "BMS 300 mg 3622"
More about Reyataz (atazanavir)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 1 Review
- Generic Availability
- Drug class: protease inhibitors
- FDA Alerts (3)
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.